“OUTLOOK OF ARBITRARY MEASURES OF FAIR AND EQUITABLE TREATMENT UNDER HEALTH URGENCY: THE WAIVER OF PHARMACEUTICAL PATENT”, TBLJ, vol. 2, no. 2, pp. 150–162, Aug. 2021, doi: 10.23920/transbuslj.v2i1.795.